S&P 500
(0.91%) 5 064.20 points
Dow Jones
(0.85%) 38 226 points
Nasdaq
(1.51%) 15 841 points
Oil
(0.08%) $79.06
Gas
(5.02%) $2.03
Gold
(0.10%) $2 313.40
Silver
(0.68%) $26.93
Platinum
(0.85%) $963.00
USD/EUR
(-0.06%) $0.932
USD/NOK
(-0.22%) $11.01
USD/GBP
(-0.05%) $0.798
USD/RUB
(-2.29%) $91.12

Realaus laiko atnaujinimai Penumbra Inc [PEN]

Birža: NYSE Sektorius: Healthcare Pramonė: Medical Devices
Upcoming Earnings Alert

5 days till quarter result
(amc 2024-05-07)

Expected move: +/- 3.97%

Atnaujinta2 geg. 2024 @ 23:00

0.38% $ 206.06

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):
Profile picture for Penumbra Inc

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands...

Stats
Šios dienos apimtis 328 317
Vidutinė apimtis 358 419
Rinkos kapitalizacija 7.99B
EPS $0 ( 2024-02-22 )
Kita pelno data ( $0.420 ) 2024-05-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 88.82
ATR14 $0.230 (0.11%)
Insider Trading
Date Person Action Amount type
2024-04-15 Roberts Johanna Sell 193 Common Stock
2024-04-01 Roberts Johanna Sell 220 Common Stock
2024-04-01 Roberts Johanna Sell 233 Common Stock
2024-04-01 Roberts Johanna Sell 109 Common Stock
2024-04-01 Roberts Johanna Sell 24 Common Stock
INSIDER POWER
-30.58
Last 100 transactions
Buy: 40 001 | Sell: 77 662

Tūris Koreliacija

Ilgas: 0.25 (neutral)
Trumpas: -0.43 (neutral)
Signal:(60.337) Neutral

Penumbra Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
DMYS0.964
TMHC0.959
LEN-B0.958
BMAC0.957
CNDB0.956
PSPC0.956
EOCW0.955
NVR0.954
MTH0.954
CXAC0.954
10 Labiausiai neigiamai susiję koreliacijos
PAK-0.946
NYC-0.945
RKLY-0.944
EVTL-0.937
DBMF-0.935
TPL-0.934
UNG-0.932
GAZ-0.932
VET-0.93
ADM-0.929

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Penumbra Inc Koreliacija - Valiuta/Žaliavos

The country flag 0.01
( neutral )
The country flag 0.19
( neutral )
The country flag 0.00
( neutral )
The country flag 0.02
( neutral )
The country flag -0.54
( weak negative )
The country flag -0.06
( neutral )

Penumbra Inc Finansinės ataskaitos

Annual 2023
Pajamos: $1.06B
Bruto pelnas: $682.64M (64.49 %)
EPS: $2.37
FY 2023
Pajamos: $1.06B
Bruto pelnas: $682.64M (64.49 %)
EPS: $2.37
FY 2022
Pajamos: $847.13M
Bruto pelnas: $535.21M (63.18 %)
EPS: $-0.0529
FY 2021
Pajamos: $747.59M
Bruto pelnas: $475.38M (63.59 %)
EPS: $0.0716

Financial Reports:

No articles found.

Penumbra Inc

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.